FSD Pharma Inc.: FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium : vimarsana.com

FSD Pharma Inc.: FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium

FSD Pharma Inc.: FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium

finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Canada , Canadian , Zeeshan Saeed , Lakshmip Kotra , Lucid Psycheceuticals Inc , Drug Administration , Fsd Pharma Inc , Nasdaq , Exchange Commission , Biosciences Inc , Symposium Of The International Cannabinoid Research Society , Scientific Affairs , Health Canada , Pharma Inc , Lucid Psycheceuticals , Investigational New Drug , Annual Symposium , International Cannabinoid Research Society , Andrzej Chruscinski , Mohammad Ebrahimzadeh , Safety Pharmacology , Psycheceuticals Inc , Canadian Securities Administrators , Executive Co Chairman ,